• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Al hip replacement. Acta Chir Scand 1985, 151:589?94. 19. Prins MH, Hirsh J: PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/20460822 A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: a critical review. Thromb Haemost 1990, 64:497?00. 20. Samama CM, Barre J, Clergue F, Samii K: [Benefits of regional anesthesia. Anticoagulant treatment and regional anesthesia]. Ann Fr Anesth Reanim 1992, 11:282?87.Rosencher et al. Thrombosis Journal 2012, 10:9 http://www.thrombosisjournal.com/content/10/1/Page 9 of21. O'Hara DA, Duff A, Berlin JA, Poses RM, Lawrence VA, Huber EC, et al: The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 2000, 92:947?57. 22. Rodgers A, Walker N, Schug S, McKee A, Kehlet H, Van ZA, et al: Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000, 321:1493. 23. Sorenson RM, Pace NL: Anesthetic techniques during surgical repair of femoral neck fractures. A meta-analysis. Anesthesiology 1992, 77:1095?104. 24. Urwin SC, Parker MJ, Griffiths R: General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth 2000, 84:450?55. 25. Friedman RJ, Dahl OE, Rosencher N, Caprini JA, Kurth AA, Francis CW, et al: Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res 2010, 126:175?82. 26. Manoir BD, Bourget P, Langlois M, Szekely B, Fischler M, Chauvin M, et al: Evaluation of the pharmacokinetic profile and analgesic efficacy of oral morphine after total hip arthroplasty. Eur J Anaesthesiol 2006, 23:748?54. 27. Dahl OE, Kurth AA, Rosencher N, Schnee JM, Clemens A, Hantel S, et al: Delay in initiating prophylactic treatment with dabigatran etxilate following total hip or knee replacement surgery did not affect efficacy. Pooled analysis of two European phase III trials [abstract]. J Thromb Haemost 2009, 7(Suppl):695. 28. Dahl OE, Kurth AA, Rosencher N, Noack H, Clemens A, Eriksson BI: Thromboprophylaxis with dabigatran etexilate in patients over seventyfive years of age with moderate renal impairment undergoing hip or knee replacement. Int Orthop 2011, 36:741?48.doi:10.1186/1477-9560-10-9 Cite this article as: Rosencher et al.: Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in 2-Chloro-5,6-dihydro-7H-cyclopenta[b]pyridin-7-one major orthopaedic surgery: pooled analysis of three randomized controlled trials. Thrombosis Journal 2012 10:9.Submit your next manuscript to BioMed Central and take full advantage of:?Convenient online submission ?Thorough peer review ?No space constraints or color figure charges ?Immediate publication on acceptance ?Inclusion 3-(tert-Butyldimethylsilyloxy)propan-1-amine in PubMed, CAS, Scopus and Google Scholar ?Research which is freely available for redistributionSubmit your PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/3971254 manuscript at www.biomedcentral.com/submit
Bratseth et al. Thrombosis Journal 2012, 10:12 http://www.thrombosisjournal.com/content/10/1/ORIGINAL CLINICAL INVESTIGATIONOpen AccessMarkers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatmentVibeke Bratseth1*, Alf- e Pettersen1,2, Trine B Opstad1,2, Harald Arnesen1,2,3 and Ingebj g Seljeflot1,2,AbstractBackground: Cardiovascular disease with disturbances in the haemostatic system, might lead to thrombotic complications with clinical manifestations like acute myocardial infarction (AMI) and stroke. Activation.